A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2006

Study Completion Date

November 30, 2009

Conditions
Neoplasms
Interventions
DRUG

ADH -1 and carboplatin

DRUG

ADH -1 and docetaxel

DRUG

ADH -1 and capecitabine

Trial Locations (10)

12208

New York Oncology Hematology P.C., Albany

23502

Virginia Oncology Associates, Norfolk

29605

Cancer Centers of the Carolinas, Greenville

34761

Cancer Centers of Florida, Ocoee

45409

Dayton Oncology & Hematology, P.A, Kettering

46219

Central Indiana Cancer Centers, Indianapolis

75246

Texas Oncology, PA, Dallas

75702

Tyler Cancer Center, Tyler

80218

Rocky Mountain Cancer Centers, Denver

98684

Northwest Cancer Specialists - Vancouver Cancer Center, Vancouver

Sponsors
All Listed Sponsors
collaborator

US Oncology Research

INDUSTRY

lead

Adherex Technologies, Inc.

INDUSTRY

NCT00390676 - A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine | Biotech Hunter | Biotech Hunter